Şayeste Akkan Eren

Şayeste Akkan Eren

Auto-generated profile, based on publicly available information

Şayeste Akkan Eren

Department of Nephrology, Ankara University, School of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2024 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
APAysel Pehlivanli
Aysel Pehlivanli
SESayeste Akkan Eren
Sayeste Akkan Eren
SSSule Sengul
Sule Sengul
BBBILGEN BASGUT
BILGEN BASGUT
SESehsuvar Erturk
Sehsuvar Erturk
AOA. Tanju Ozcelikay
A. Tanju Ozcelikay
Background: Dialysis patients are at high risk for drug-related problems (DRPs), which have significant consequences for their morbidity, mortality, and quality of life. Improved clinical outcomes can be achieved by preventing, identifying, and resolving these problems. Methods: This is a retrospective observational study. In this study, the PAIR instrument (Pharmacotherapy Assessment in Chronic Renal Disease) was validated for use in Turkish. Validation consisted of three stages: translation back-translation with expert panel evaluation, reliability analysis using the test-retest method, and conceptual validity with both Pharmaceutical Care Network Europe (PCNE) and PAIR used to determine DRPs prevalence. Results: In total, 104 patients (mean ± SD age, 54.1 ± 15.8 years; 53.8% male) were included in the study. An expert panel evaluated the items in the criterion based on their intelligibility, service of purpose, differentiation, and cultural suitability during the translation stage. Content validity index (CVI) score was found to be 0.95. The reliability analysis was performed by applying the test-retest method and calculating correlation coefficient on 30 randomly selected patients one month later. Correlation coefficient (p) was found to be 0.8. To evaluate conceptual validity, 104 patients’ pharmacotherapy plans were assessed using both the PAIR and PCNE criteria. The prevalence of DRPs according to PAIR criteria (100.0%) and PCNE (73.1%) were statistically significantly different (p < 0.001). Conclusions: As a result, PAIR criteria can identify clinically relevant DRPs in patients with CKD and is a new, validated tool to be used in Turkey, but may not be adequate for patients receiving dialysis. Therefore, it needs to be reviewed and updated for dialysis patients.

25 May 2021 in Journal of Ankara University Faculty of Medicine
Verified
Journal Article
Open access
RSRezzan Eren Sadioğlu
Rezzan Eren Sadioğlu
MAMerve Aktar
Merve Aktar
GÇGülden Bolat Çelik
Gülden Bolat Çelik
EAElif Açıkgöz
Elif Açıkgöz
ŞEŞayeste Akkan Eren
Şayeste Akkan Eren
KAKenan Ateş
Kenan Ateş

5 April 2024 in Journal of Ankara University Faculty of Medicine
Verified
Journal Article
Closed access
GKGizem Kumru
Gizem Kumru
MAMerve Aktar
Merve Aktar
ŞEŞayeste Akkan Eren
Şayeste Akkan Eren
SSSule Sengul
Sule Sengul
KKKenan Keven
Kenan Keven

24 October 2023 in Journal of Ankara University Faculty of Medicine
Verified
Journal Article
Closed access
ŞEŞayeste Akkan Eren
Şayeste Akkan Eren
GKGizem Kumru
Gizem Kumru
KKKenan Keven
Kenan Keven

30 September 2025 in Turkish Journal of Nephrology
Verified
Journal Article
Open access
GKGizem Kumru
Gizem Kumru
ŞEŞayeste Akkan Eren
Şayeste Akkan Eren
SSSule Sengul
Sule Sengul
KAKenan Ateş
Kenan Ateş
KKKenan Keven
Kenan Keven
Kidney transplantation,peritoneal dialysis,peritoneal dialysis discontinuation,peritonitis,time on peritoneal dialysis,transplant failure